Results 111 to 120 of about 61,305 (194)

OMG! Otra Moda Grita

, 2013
Universidad Nacional de La ...
Bigne, María Laura, Faloco, Carolina, Galli, Paula Anahí, Reynoso, Elina   +3 more
openaire   +1 more source

Lipase Treatment for Pitch Control in Recycled Pulps: Application in a Duplex Board Mill

BioResources
This study evaluated whether lipase enzymes could control pitch contamination in recycled pulps from a duplex board mill. The pitch contents of four recycled pulp types—old magazine paper (OMG), old book paper (OB), old newspaper (ONP), and old ...
Min Seo Kim, Ji Hyun Tak, Ji Young Lee, Kyoung Sik Shin   +3 more
doaj  

La supervisión de cultivos agrícolas como práctica de vigilancia dirigida a identificar los efectos de los OMG sobre la salud humana o el medio ambiente.

Bioderecho.es, 2017
El objetivo de esta comunicación es dar cuenta de la última modificación de la regulación europea sobre Organismos Modificados Genéticamente (en adelante OMG), en lo que respecta a la posibilidad de que los Estados miembros restrinjan o prohíban el ...
Isabel Hernández San Juan
doaj  

Thymectomy in Ocular Myasthenia Gravis: Results Before and After Generalization and Prognostic Predictors of Outcomes. [PDF]

J Clin Med
Nachira D, Congedo MT, Kuzmych K, Evoli A, Iorio R, Vita ML, Petracca-Ciavarella L, Nocera A, Sassorossi C, Evangelista J, Lyberis P, Comacchio GM, Brandolini J, Aprile V, Zifara CC, Mastromarino MG, Patirelis A, Asteggiano E, Anile M, Venuta F, Imperatori A, Ambrogi V, Solli P, Dell'Amore A, Lucchi M, Melfi F, Ibrahim M, Ruffini E, Rea F, Margaritora S, Meacci E.   +30 more
europepmc   +1 more source

Cavernous Sinus Dural Arteriovenous Fistula Initially Misdiagnosed As Ocular Myasthenia Gravis: A Case Report. [PDF]

Cureus
Yamamoto S, Watanabe G, Akao G, Sato K, Suzuki Y.   +4 more
europepmc   +1 more source

Clinical Features and Outcomes of Ocular Myasthenia Gravis in a Tertiary Philippine Hospital. [PDF]

Acta Med Philipp
Labiano AT, Cruz FMO, Mesina BVQ.
europepmc   +1 more source

Exploring the impact of age of onset on stereoacuity in patients with myasthenia gravis. [PDF]

Front Ophthalmol (Lausanne)
Cheng CY, Chiu HC, Hung CF, Yeh JH.
europepmc   +1 more source

Risk factors for generalization of ocular myasthenia gravis. [PDF]

Indian J Ophthalmol
Djordjevic IS, Peric S, Djordjevic SA, Lavrnic D, Marasevic K, Apostolski S, Kosac A, Basta I.   +7 more
europepmc   +1 more source

Diagnostic Performance of Three Serological Assays in Myasthenia Gravis: A Prospective Multicentre Study. [PDF]

Scand J Immunol
Cuomo L, De Giglio L, Isgrò MA, Totaro M, Pratali M, Fragomeli C, Cosmi L, Annunziato F, Palterer B, Altavista MC, Antonini G, Brienza M, Cambieri C, Cortese F, Fionda L, Gragnani F, Inghilleri M, Morino S, Petrucci A, Piantadosi C, Anastasiadou E, Vitillo M, Trivedi P, Pennisi EM.   +23 more
europepmc   +1 more source

Low-dose rituximab in AChR antibody-positive ocular myasthenia gravis: Efficacy and safety-A preliminary study. [PDF]

Medicine (Baltimore)
Mao B, Wang R, Liu X, Ping D, Xu Y, Ning L.   +5 more
europepmc   +1 more source